SCHEMBL2200965

SCHEMBL2200965

CCOC(=O)c1ccc2ccccc2c1Br

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDC25B P30305 2/20 0.60
▸ TSHR P16473 1/20 0.56
▸ CDC25A P30304 1/20 0.56
▸ CDC25C P30307 1/20 0.56
▸ KDM4E B2RXH2 5/20 0.54
▸ ALDH1A1 P00352 5/20 0.54
▸ GLA P06280 1/20 0.54
▸ GAA P10253 1/20 0.54
▸ KMT2A Q03164 3/20 0.53
▸ NPC1 O15118 2/20 0.53
▸ RAB9A P51151 2/20 0.53
▸ MEN1 O00255 1/20 0.53
▸ TDP1 Q9NUW8 1/20 0.52
▸ MAPK1 P28482 1/20 0.51
▸ L3MBTL1 Q9Y468 1/20 0.51
▸ PRNP P04156 1/20 0.49
▸ RXFP1 Q9HBX9 1/20 0.49
▸ MAPT P10636 1/20 0.49
▸ SMN1; SMN2 Q16637 1/20 0.49
▸ HSD17B10 Q99714 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11342375 0.85 PRNP (0.47) CDC25BCDC25ACDC25CKDM4EALDH1A1
SCHEMBL22610038 0.84 CDC25B (0.63) CDC25BTSHRCDC25ACDC25CKDM4E
SCHEMBL13880496 0.84 CDC25B (0.63) CDC25BTSHRCDC25ACDC25CKDM4E
SCHEMBL8773458 0.83 HCRTR1 (0.62) CDC25BTSHRCDC25ACDC25CKDM4E
SCHEMBL29856064 0.83 CDC25B (0.61) CDC25BTSHRCDC25ACDC25CKDM4E
SCHEMBL560585 0.83 CDC25B (0.61) CDC25BTSHRCDC25ACDC25CKDM4E
SCHEMBL163227 0.83 CDC25B (0.61) CDC25BTSHRCDC25ACDC25CKDM4E
SCHEMBL2606588 0.82 NCEH1 (0.53) TSHRKDM4EALDH1A1KMT2ANPC1
SCHEMBL22261540 0.82 CDC25B (0.57) CDC25BTSHRCDC25ACDC25CKDM4E
SCHEMBL29134058 0.82 ALDH1A1 (0.54) TSHRKDM4EALDH1A1KMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11737352-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2023-08-22 — — US disclosed
US-11737352-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2023-08-22 — — US disclosed
US-11737352-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2023-08-22 — — US disclosed
US-11578063-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2023-02-14 — — US disclosed
US-20210367155-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2021-11-25 — — US disclosed
EP-3571264-B1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2021-11-24 — — EP disclosed
EP-3571264-B1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2021-11-24 — — EP disclosed
US-11158816-B2 6,9,15,18-tetrahydro-s-indaceno[1,2-b:5,6-b′]difluorene derivatives and use thereof in electronic devices MERCK PATENT GMBH (DE) 2021-10-26 — — US disclosed
CN-107848911-B 6,9,15, 18-tetrahydro-symmetrical indaceno [1,2-B:5, 6-B' ] bifluorene derivative and application thereof in electronic devices 默克专利有限公司 2021-08-31 — — CN disclosed
EP-3792235-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES Merck Patent GmbH (DE) 2021-03-17 — — EP disclosed
WO-2016096069-A1 COMPOUNDS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2016-06-23 — — WO disclosed
US-20140299851-A1 Organic Electroluminescence Element UDC IRELAND LIMITED (IE) 2014-10-09 — — US disclosed
US-20140299851-A1 Organic Electroluminescence Element UDC IRELAND LIMITED (IE) 2014-10-09 — — US disclosed
WO-2014111269-A2 MATERIALS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2014-07-24 — — WO disclosed
EP-1964861-B1 ACETYLENE-BASED POLYMER NAT INST OF ADVANCED IND SCIEN (JP) 2012-10-17 — — EP disclosed
US-7977441-B2 Acetylene-based polymer NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 2011-07-12 — — US disclosed
US-7674822-B2 protein tyrosine phosphatase 1B (PTP1B) modulators; type 2 diabetes, obesity; increasing insulin sensitivity; 1-Carboxymethoxy-3,8-dithia-cyclopenta[a]indene-2-carboxylic acid WYETH (US) 2010-03-09 — — US disclosed
US-20090253872-A1 Acetylene-Based Polymer NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 2009-10-08 — — US disclosed
EP-1964861-A1 ACETYLENE POLYMER National Institute of Advanced Industrial Science and Technology (JP) 2008-09-03 — — EP disclosed
US-20060135488-A1 protein tyrosine phosphatase 1B (PTP1B) modulators; type 2 diabetes, obesity; increasing insulin sensitivity; 1-Carboxymethoxy-3,8-dithia-cyclopenta[a]indene-2-carboxylic acid WYETH 2006-06-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11158816-B2 6,9,15,18-tetrahydro-s-indaceno[1,2-b:5,6-b′]difluorene derivatives and use thereof in electronic devices INF2, ETFB, INTS9 CDC25B 2842/4885TSHR 3789/4885CDC25A 4417/4885
US-20210367155-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES EPB41, EPB41L2, MCM4 CDC25B 2403/4885TSHR 4716/4885CDC25A 2069/4885
US-11737352-B2 Materials for organic electroluminescent devices EPB41, EPB41L2, MCM4 CDC25B 2403/4885TSHR 4716/4885CDC25A 2069/4885
US-11578063-B2 Materials for organic electroluminescent devices GPX1, EPCAM, EFNA1 CDC25B 2969/4885TSHR 4776/4885CDC25A 2411/4885
US-20060135488-A1 protein tyrosine phosphatase 1B (PTP1B) modulators; type 2 diabetes, obesity; increasing insulin sensitivity; 1-Carboxymethoxy-3,8-dithia-cyclopenta[a]indene-2-carboxylic acid PTPA, PTPRCAP, PTPRC CDC25B 384/4885TSHR 1327/4885CDC25A 366/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback